<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:d3625bdc-7ad9-4f6d-a1c9-801b2b3e96c8,g:2451a044-66b4-4b48-b5bc-97083bf24cf7,d:fd5b0818e45a4e9da0b6c971b1c95933--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20201013</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM180L2ZyYWc6MWZkNzk2ZGY2MTFlNDI0OWJmNDViNjdhNTA1NWFlYjUvdGFibGU6MWVlOGY3YWI2YWRjNDY2NGIzZTU0Zjg3N2JmODUwMjQvdGFibGVyYW5nZToxZWU4ZjdhYjZhZGM0NjY0YjNlNTRmODc3YmY4NTAyNF8yLTEtMS0xLTA_4a219492-247e-47c0-9ed6-b6a012f8a131">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM180L2ZyYWc6MWZkNzk2ZGY2MTFlNDI0OWJmNDViNjdhNTA1NWFlYjUvdGFibGU6MWVlOGY3YWI2YWRjNDY2NGIzZTU0Zjg3N2JmODUwMjQvdGFibGVyYW5nZToxZWU4ZjdhYjZhZGM0NjY0YjNlNTRmODc3YmY4NTAyNF8zLTEtMS0xLTA_320b0c04-8b8a-4438-aba2-5ca7763959fc">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20201013.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-16</xbrli:startDate><xbrli:endDate>2020-06-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifd5b0818e45a4e9da0b6c971b1c95933_1"></div><div style="min-height:36pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ3_2a848d95-b750-4c18-8d93-c6db54d04c12">8-K</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CURRENT REPORT</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Securities Exchange Act of 1934</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18yMzI_3fd73adb-3835-4aa6-8156-1f18ff45cf58">October 13, 2020</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQz_78b5f51c-3fa1-494f-a811-c7e571e9af74">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> (Exact Name of Registrant as Specified in Charter)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.948%;"><tr><td style="width:1.0%;"></td><td style="width:18.210%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.037%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.244%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:20.968%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.244%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.697%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl8wLTAtMS0xLTA_1d76654f-0618-4c1c-859c-595a64bb8e60">Delaware</ix:nonNumeric></span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl8wLTMtMS0xLTA_42c3a011-8c35-4186-a07a-9812a2338bc0">001-36112</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl8wLTUtMS0xLTA_10c5d9d9-bfb7-4eb4-9ae5-e541f0e8dc90">06-1591613</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Commission<br/>File Number)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">(IRS Employer</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;">&#160;Identification No.)</span></div></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl8zLTAtMS0xLTA_58a4e03f-742b-44c5-be8e-dcb53064cb70">9704 Medical Center Drive</ix:nonNumeric></span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl80LTAtMS0xLTA_08b4b26e-75c2-4f24-b8ad-3ee453bf51ca">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl80LTEtMS0xLTA_777d8e08-64f5-41c7-bbe4-a604f7a88c0f">Maryland</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6MDgyOGZhYmUxY2MwNDk1OWI3MDgzYzgxMmQ5YmQ5Y2IvdGFibGVyYW5nZTowODI4ZmFiZTFjYzA0OTU5YjcwODNjODEyZDliZDljYl80LTMtMS0xLTA_b711333c-5803-465d-9a17-6dc2a3808b3c">20850</ix:nonNumeric></span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Address of Principal Executive Offices)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Zip Code)</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant's telephone number, including area code:&#160; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">(<ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ0_9eadba83-d01c-4843-a741-6de22ee417bc">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ1_7dd43b3f-d4cc-4d4c-b76c-5e51d8296ee3">251-5172</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Not applicable&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center;"><span><br/></span></div><div style="padding-right:15.75pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-right:15.75pt;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:35.541%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.052%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:42.107%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6YzRkYWYwYjMyMzdlNDliNzhhODI5NDA0N2NlZmMzMDQvdGFibGVyYW5nZTpjNGRhZjBiMzIzN2U0OWI3OGE4Mjk0MDQ3Y2VmYzMwNF8xLTAtMS0xLTA_b85077d4-5c1c-499a-94d4-a4292cc297b8">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6YzRkYWYwYjMyMzdlNDliNzhhODI5NDA0N2NlZmMzMDQvdGFibGVyYW5nZTpjNGRhZjBiMzIzN2U0OWI3OGE4Mjk0MDQ3Y2VmYzMwNF8xLTEtMS0xLTA_49cd4aa4-df28-4c50-9563-1a4bb19f7113">MGNX</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGFibGU6YzRkYWYwYjMyMzdlNDliNzhhODI5NDA0N2NlZmMzMDQvdGFibGVyYW5nZTpjNGRhZjBiMzIzN2U0OWI3OGE4Mjk0MDQ3Y2VmYzMwNF8xLTItMS0xLTA_40b3e09c-2615-4575-85cc-518580415d38">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:36pt;margin-bottom:5.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ4_db436e74-3655-40d5-9cf7-519e0703ba7a">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ5_b44eeb92-3ed4-4153-9073-489efdd44c8e">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQ2_8a6aee7d-96a3-4e63-97a3-09956f2cf725">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjQy_90494ff7-c051-4666-9c1a-9584ccb5f7b5">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:3pt;"><span><br/></span></div><div style="margin-top:5pt;margin-bottom:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Emerging growth company  <ix:nonNumeric contextRef="i5ee4fc3f7cf24d1b8f7c3c5802d45984_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZkNWIwODE4ZTQ1YTRlOWRhMGI2Yzk3MWIxYzk1OTMzL3NlYzpmZDViMDgxOGU0NWE0ZTlkYTBiNmM5NzFiMWM5NTkzM18xL2ZyYWc6ZmM4ODFiZDRmNDUxNDYwNmJkMzBjZGUzNjY0MGY3MjMvdGV4dHJlZ2lvbjpmYzg4MWJkNGY0NTE0NjA2YmQzMGNkZTM2NjQwZjcyM18xNjUw_0dcc12ef-bcd4-49a3-9d22-e5e3e1e232ba">&#9744;</ix:nonNumeric></span></div><div style="margin-top:5pt;margin-bottom:5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="position:relative;width:100%;height:36pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="ifd5b0818e45a4e9da0b6c971b1c95933_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:15.322%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:82.478%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 1.01</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Entry into a Material Definitive Agreement</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On October&#160;13, 2020,  MacroGenics, Inc. (the &#8220;Company&#8221;) entered into a Commercial Supply Agreement (the &#8220;Commercial Supply Agreement&#8221;) with Incyte Corporation (&#8220;Incyte&#8221;). The Company and Incyte are parties to that certain Global Collaboration and License Agreement, dated October 24, 2017, in which the Company granted to Incyte an exclusive license to develop, manufacture and commercialize retifanlimab (the &#8220;Collaboration and License Agreement&#8221;).  The Commercial Supply Agreement was entered into as contemplated by the Collaboration and License Agreement, pursuant to which the Company is entitled to manufacture a portion of the global commercial supply needs for retifanlimab (formerly designated as MGA012 by the Company). The Company plans to manufacture commercial retifanlimab at its 5 x 2,000L scale GMP facility in Rockville, MD.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Unless terminated earlier, the term of the Commercial Supply Agreement will expire upon the expiration of Incyte&#8217;s obligation to pay royalties under the Collaboration and License Agreement.  The Commercial Supply Agreement also includes customary provisions relating to, among others, production forecasting, delivery, inspection procedures, warranties, confidentiality and indemnification. The foregoing description of the Commercial Supply Agreement does not purport to be complete and is qualified in its entirety by reference to the complete Commercial Supply Agreement, which will be filed in redacted form as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ending December 31, 2020.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ifd5b0818e45a4e9da0b6c971b1c95933_13"></div><div style="text-align:center;margin-top:3pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SIGNATURE</span></div><div style="text-indent:36pt;margin-top:3pt;margin-bottom:3pt;"><span><br/></span></div><div style="text-indent:36pt;margin-top:3pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-indent:36pt;margin-top:3pt;margin-bottom:3pt;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.032%;"><tr><td style="width:1.0%;"></td><td style="width:44.937%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.488%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:45.275%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">MACROGENICS, INC.</span></div></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date:  October 16, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">By:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Name:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Title:</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;">/s/ Jeffrey Peters</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Jeffrey Peters</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mgnx-20201013.htm", "description": "8-K", "secsgml_size_bytes": 37698}]
{"company-data": {"conformed-name": "MACROGENICS INC", "cik": "0001125345", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36112", "film-number": "201243083"}, "business-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "Rockville", "state": "MD", "zip": "20850", "phone": "301-251-5172"}, "mail-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "ROCKVILLE", "state": "MD", "zip": "20850"}}
mgnx-20201013
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
October 13, 2020
MACROGENICS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-36112
06-1591613
(State or Other Jurisdiction of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
9704 Medical Center Drive
Rockville,
Maryland
20850
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(
301
)
251-5172
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
MGNX
Nasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
Item 1.01
Entry into a Material Definitive Agreement
On October 13, 2020,  MacroGenics, Inc. (the "Company") entered into a Commercial Supply Agreement (the "Commercial Supply Agreement") with Incyte Corporation ("Incyte"). The Company and Incyte are parties to that certain Global Collaboration and License Agreement, dated October 24, 2017, in which the Company granted to Incyte an exclusive license to develop, manufacture and commercialize retifanlimab (the "Collaboration and License Agreement").  The Commercial Supply Agreement was entered into as contemplated by the Collaboration and License Agreement, pursuant to which the Company is entitled to manufacture a portion of the global commercial supply needs for retifanlimab (formerly designated as MGA012 by the Company). The Company plans to manufacture commercial retifanlimab at its 5 x 2,000L scale GMP facility in Rockville, MD.
Unless terminated earlier, the term of the Commercial Supply Agreement will expire upon the expiration of Incyte's obligation to pay royalties under the Collaboration and License Agreement.  The Commercial Supply Agreement also includes customary provisions relating to, among others, production forecasting, delivery, inspection procedures, warranties, confidentiality and indemnification. The foregoing description of the Commercial Supply Agreement does not purport to be complete and is qualified in its entirety by reference to the complete Commercial Supply Agreement, which will be filed in redacted form as an exhibit to the Company's Annual Report on Form 10-K for the year ending December 31, 2020.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MACROGENICS, INC.
Date:  October 16, 2020
By:
Name:
Title:
/s/ Jeffrey Peters
Jeffrey Peters
Vice President and General Counsel